SCHEMBL8410948

SCHEMBL8410948

CCOC1(OCC)CCc2c(ccc3oc4ccccc4c23)O1

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ AHR P35869 1/20 0.30
▸ MAOA P21397 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ CASP3 P42574 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SENP8 Q96LD8 1/20 0.30
▸ SENP7 Q9BQF6 1/20 0.30
▸ SENP6 Q9GZR1 1/20 0.30
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8563345 0.80 MAOA (0.42) KDM4EALDH1A1CYP3A4HPGDHSD17B10
SCHEMBL5260241 0.79 HPGD (0.43) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL11308544 0.69 SIGMAR1 (0.46) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL8949582 0.65 GPR119 (0.43) CYP3A4CYP2D6CYP2C19
SCHEMBL16622181 0.63 NFKB1 (0.40) —
SCHEMBL1635475 0.61 MAOA (0.59) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL14541236 0.61 NFE2L2 (0.47) CYP3A4HPGDMAOALMNA
SCHEMBL29454006 0.60 MAOA (0.43) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL13990695 0.60 CYP2A6 (0.57) KDM4EALDH1A1L3MBTL1HPGDMAOA
SCHEMBL28574487 0.60 MAOA (0.50) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998454-A ANTIINFLAMMATORY AGENT; EYES ELI LILLY AND COMPANY (US) 1999-12-07 — — US disclosed
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 — — EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 — — WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 — — EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 — — US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 — — EP disclosed
Send feedback